The estimated Net Worth of Charles A Sanders is at least $3.32 Milion dollars as of 13 March 2012. Charles Sanders owns over 2,000 units of Vertex Pharmaceuticals stock worth over $3,323,180 and over the last 21 years Charles sold VRTX stock worth over $0.
Charles has made over 16 trades of the Vertex Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently Charles bought 2,000 units of VRTX stock worth $10,440 on 13 March 2012.
The largest trade Charles's ever made was buying 20,000 units of Vertex Pharmaceuticals stock on 12 November 2003 worth over $165,600. On average, Charles trades about 2,081 units every 82 days since 2003. As of 13 March 2012 Charles still owns at least 7,000 units of Vertex Pharmaceuticals stock.
You can see the complete history of Charles Sanders stock trades at the bottom of the page.
Charles's mailing address filed with the SEC is 2190 PARKWAY LAKE DR, , BIRMINGHAM, AL, 35244.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden a Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: